DELPHI MANAGEMENT INC /MA/

Position in ABBV — AbbVie Inc.

CIK 767684 BROOKLINE, MA

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,487,444

+$334,313 QoQ

Shares Held

5,911

+11.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

#2,181

of 4,153 holders

Holding Since

Mar 2021

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DELPHI MANAGEMENT INC /MA/ holds $2,738,383 across 2 Drug Manufacturers - General names. ABBV ranks #1 (54.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ABBV	AbbVie Inc. This page	5,911	$1,487,444
2	NVS	Novartis AG	7,982	$1,250,939

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,487,444	5,911	+11.5%	Shares	Sole	2026-07-31
2026-03-31	$1,153,131	5,302	-21.1%	Shares	Sole	2026-04-20
2025-12-31	$1,535,452	6,720	-3.0%	Shares	Sole	2026-01-21
2025-09-30	$1,604,572	6,930	+23.6%	Shares	Sole	2025-10-15
2025-06-30	$1,040,771	5,607	-6.6%	Shares	Sole	2025-07-07
2025-03-31	$1,258,167	6,005	-9.3%	Shares	Sole	2025-04-08
2024-12-31	$1,176,374	6,620	-1.1%	Shares	Sole	2025-02-10
2024-09-30	$1,321,733	6,693	-15.5%	Shares	Sole	2025-02-10
2024-06-30	$1,358,095	7,918	+0.2%	Shares	Sole	2024-08-26
2024-03-31	$1,439,682	7,906	-14.6%	Shares	Sole	2024-05-21
2023-12-31	$1,124	9,257	+16.6%	Shares	Sole	2024-05-20
2023-09-30	$1,183,685	7,941	+0.2%	Shares	Sole	2024-01-25
2023-06-30	$1,067,735	7,925	-2.9%	Shares	Sole	2023-08-28
2022-12-31	$1,318,575	8,159	-32.3%	Shares	Sole	2023-07-11
2021-12-31	$1,632,111	12,054	+3.4%	Shares	Sole	2022-02-15
2021-09-30	$1,257,548	11,658	+1.1%	Shares	Sole	2021-11-15
2021-06-30	$1,298,964	11,532	+2.1%	Shares	Sole	2021-08-16
2021-03-31	$1,222,453	11,296	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.